In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Cancellation of EuroPRevent 2016

ESC Press Office Statement



13 April 2016:  The EACPR Board has taken the difficult decision to cancel EuroPRevent 2016 which was scheduled to take place in Istanbul from 5 to 7 May 2016.

Numerous concerns have been expressed by delegates, sponsors, and faculty in the past few weeks, and based on the safety risk we feel this is the most sensible decision.

We apologise for this inconvenience and acknowledge the extraordinary efforts and collaboration of the Turkish Society of Cardiology and the local partners during the preparation of the congress.

Given the importance of spreading the most updated scientific information in cardiovascular prevention throughout our community we are currently exploring our options and will come back to you as soon as possible.

Notes to editor

ESC Press Office
Tel: +33 (0) 4 92 94 86 27
Email: press@escardio.org

 

About EuroPReventEuroPRevent, the world's leading congress in preventive cardiology, is organised by the European Association for Cardiovascular Prevention and Rehabilitation (EACPR), a registered branch of the ESC.

 

About the European Association for Cardiovascular Prevention and Rehabilitation
The European Association for Cardiovascular Prevention & Rehabilitation (EACPR) is a registered branch of the ESC. Its aim is to promote excellence in research, practice, education and policy in cardiovascular prevention and rehabilitation in Europe.

 

About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 95 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.